News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Katsuaki Maehara: Non-G12C KRAS mutations
Katsuaki Maehara/X
Nov 16, 2024, 20:00

Katsuaki Maehara: Non-G12C KRAS mutations

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:

“Non-G12C KRAS mutations:

  • H and N SCC
  • Lung adeno
  • Cutaneous melanoma
  • Thyroid
  • PDAC
  • Colorectal
  • Bladder urothelial.”

Katsuaki Maehara: Non-G12C KRAS mutations

More posts featuring Katsuaki Maehara.

cancer Katsuaki Maehara OncoDaily Oncology
Special Coverage
Blog
Feb 21, 2025, 10:00
Alexios Matikas: Adjuvant endocrine treatment strategies for non-metastatic breast cancer
Blog
Feb 21, 2025, 09:58
Miriam Mutebi: February - a whirlwind of learning, collaboration, and action
Blog
Feb 21, 2025, 09:54
The publication of the European Commission Work Programme for 2025 - ESMO
Blog
Feb 21, 2025, 09:45
Michelle Kirschner: New programming at the Cancer Survivorship Provider Network
Science
Feb 21, 2025, 09:39
M. Bilal Abid: Excited to present at the UT San Antonio MD Anderson Cancer Center
Blog
Feb 21, 2025, 09:35
UICC is seeking an Executive Director to lead the ATOM Coalition in Geneva
Blog
Feb 21, 2025, 09:18
Belén Garijo: A very important evolution of Merck Group's Executive Board
Blog
Feb 21, 2025, 09:07
Karen Knudsen: Integrating technology into clinical practice
Blog
Feb 21, 2025, 09:00
ICCD 2025 Event Highlights: Speakers’ Quote Series - SIOP Europe
Blog
Feb 21, 2025, 08:48
Emily Drake: Delivery of palliative and end-of-life care for AYAs living with cancer
Blog
Feb 21, 2025, 08:19
Chibuike Okafor: How Amgen Defeated the ‘Undruggable’ KRAS
Insight
Feb 21, 2025, 06:20
Gustavo Viani: New Evidence on Elective CTV in Early Anal Cancer